Spontaneous gram-negative meningitis: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 21: Line 21:


* CNS dosed antibiotics to complete 21 days is typically sufficient
* CNS dosed antibiotics to complete 21 days is typically sufficient
{| class="wikitable sortable"

!Organism
!First-line
!Second-line
!Duration
|-
|''[[E. coli]]'' and other [[Enterobacteriaceae]]||third-generation cephalosporin||[[ampicillin]], [[meropenem]], [[aztreonam]], [[TMP-SMX]], or [[ciprofloxacin]]
| rowspan="3" |21 days
|-
|''[[Pseudomonas aeruginosa]]''||[[cefipime]] or [[ceftazidime]]||[[meropenem]], [[aztreonam]], or [[ciprofloxacin]]
|-
|ESBL Gram-negative bacillus||[[meropenem]]||[[cefepime]] or a fluoroquinolone
|-
|''[[Haemophilus influenzae]]'' (β-lactamase negative)||[[ampicillin]]||third-generation cephalosporin, [[cefepime]], [[chloramphenicol]], or a fluoroquinolone
| rowspan="2" |7 days
|-
|''[[Haemophilus influenzae]]'' (β-lactamase positive)||third-generation cephalosporin||[[cefepime]], [[chloramphenicol]], or a fluoroquinolone
|}
[[Category:CNS infections]]
[[Category:CNS infections]]

Revision as of 16:26, 19 July 2023

Background

Microbiology

Risk Factors

Clinical Presentation

Management

  • CNS dosed antibiotics to complete 21 days is typically sufficient
Organism First-line Second-line Duration
E. coli and other Enterobacteriaceae third-generation cephalosporin ampicillin, meropenem, aztreonam, TMP-SMX, or ciprofloxacin 21 days
Pseudomonas aeruginosa cefipime or ceftazidime meropenem, aztreonam, or ciprofloxacin
ESBL Gram-negative bacillus meropenem cefepime or a fluoroquinolone
Haemophilus influenzae (β-lactamase negative) ampicillin third-generation cephalosporin, cefepime, chloramphenicol, or a fluoroquinolone 7 days
Haemophilus influenzae (β-lactamase positive) third-generation cephalosporin cefepime, chloramphenicol, or a fluoroquinolone